Table 1

Univariate and multivariate Cox regression analyses of potential correlations between different clinicopathological parameters and survival of patients with CRC

VariableHR (95% CI)p Value
Univariate Cox regression analysis
 Age1.02 (0.99 to 1.04)0.2200
 Sex
 Male (n=92)0.64 (0.35 to 1.19)0.1600
 Female (n=56)1.00
Tumour localisation
 Right colon (n=28)1.03 (0.46 to 2.33)0.9400
 Left colon or rectum (n=120)1.00
Differentiation
 Low (n=4)0.73 (0.10 to 5.32)0.7600
 Medium (n=139)1.00
 High (n=5)3.40 (1.04 to 11.06)0.0400
TNM
 1 (n=12)0.04 (0.006 to 0.33)0.0024
 2 (n=61)0.08 (0.04 to 0.20)0.0000
 3 (n=55)0.16 (0.07 to 0.32)0.0000
 4 (n=20)1.00
Hypermutation
 Yes (n=14)0.53 (0.13 to 2.21)0.39
 No (n=134)1.00
MSI
 Negative (n=111)1.00
 Low (n=18)0.95 (0.4 to 2.26)0.9000
 High (n=19)0.34 (0.08 to 1.41)0.1400
KRAS G12/13X
 Negative (n=103)1.00
 Positive (n=45)0.87 (0.44 to 1.74)0.6920
Prognostic signature mutation
 Yes (n=40)0.21 (0.064 to 0.67)0.0091
 No (n=108)1.00
Multivariate Cox regression analysis
Differentiation
 Low (n=4)1.55 (0.20 to 12.0)0.68
 Medium (n=146)1
 High (n=5)0.99 (0.29 to 3.40)0.99
TNM
 1 (n=12)0.05 (0.006 to 0.36)0.0033
 2 (n=66)0.09 (0.04 to 0.21)0.0000
 3 (n=57)0.16 (0.08 to 0.34)0.0000
 4 (n=20)1
Prognostic signature mutation
 Yes (n=38)0.27 (0.083 to 0.89)0.031
 No (n=117)1
  • p Values <0.05 were bolded.

  • Low TNM staging and mutation(s) in a five-gene signature composed of CDH10, COL6A3, SMAD4, TMEM132D and VCAN conferred significantly lower hazard ratios in both analyses. Patients with undermined MSI status were excluded from univariate analysis but included in multivariate analysis. Patients with missing survival data were excluded from both analyses.

  • MSI, microsatellite instability.